Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0MLOQN
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
NI-2201
|
|||||
| Synonyms |
NI 2201; NI2201
Click to Show/Hide
|
|||||
| Organization |
Novimmune SA; LegoChem Biosciences, Inc.; Berta Holding AG; Iksuda Therapeutics Ltd.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
B-lymphocyte antigen CD19 (CD19)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||